Topic

Articles

The passing of Supreme Court Justice Ruth Bader Ginsburg has thrown an already contentious election season into greater limbo, as her death and potential replacement could result in substantial changes to the future of the Affordable Care Act and women’s reproductive rights. 

How a Supreme Court Vacancy Can Shape the Fate of the ACA, Reproductive Rights

Videos

Given the constraints prevalent post-COVID-19, Dr Mark Fendrick, director of the University of Michigan Center for Value-Based Insurance Design, stresses that it is now more important than ever for the health care industry to prioritize payment reform, value-based benefit design, and novel policy initiatives.

How Can the COVID-19 Pandemic Enhance Value-Based Health Care Delivery?

Podcasts

Krisda H. Chaiyachati, MD, MPH, MSHP, discusses the study he co-wrote entitled “Economic Outcomes of Insurer-Led Care Management for High-Cost Medicaid Patients.” 

Can a Community-Based Care Management Program Reduce Costs, Visits Among Medicaid Enrollees?

The orders President Trump signed Friday include a deadline for the pharmaceutical industry to come up with their own plan by August 24 to lower prices. 

Trump Signs 4 Executive Orders in Effort to Carry Out Promise to Lower Drug Prices

The US government partners with biotech giants Pfizer and BioNTech to distribute a coronavirus disease 2019 (COVID-19) vaccine; the COVID-19 death record continues to be broken; could Medicare be in financial trouble?

What We're Reading: Vaccine Distribution Agreement Announced; Virus Deaths Surge Again; Medicare Insolvency Predicted

End-stage renal disease has long been one of the most expensive and debilitating conditions that affects Medicare beneficiaries. Not only does dialysis cost $90,000 a year&mdash;those awaiting a kidney transplant automatically qualify for Medicare&mdash;but the need to travel to a dialysis center multiple times a week disrupts employment and home life.

CMS Seeks Incentives for At-Home Dialysis in Wake of COVID-19

Significant populations of seriously ill individuals are insured by all lines of business and have meaningfully different needs and medical histories in California.

Gauging the Experiences of the Seriously Ill in California: Analyzing Serious Illness Beyond Medicare Fee-for-Service

Among Medicare enrollees, there was substantial between-practice variation in the use of second-generation diabetes drugs between 2007 and 2015, according to a study published in JAMA Network Open. Data also revealed a concentration of use among a few prescribers and practices, who were responsible for widespread early diffusion.

Study Highlights Variation in Second-Generation Diabetes Drug Use Among Medicare Enrollees

The objective of this research was to identify strategies that significantly lower unnecessary inpatient utilization among Medicare beneficiaries with chronic disease.

Strategies for Implementing Best Practices in Independent Physician Associations

The announcement of a $35 per month out-of-pocket cap for insulin for some individuals with Medicare is a real victory for the American Diabetes Association and for people with diabetes, said Robert Gabbay, MD, PhD, chief medical and scientific officer of the American Diabetes Association.

Insurance

New content coming soon, please check back later.